Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Cancer Vaccines01:30

Cancer Vaccines

548
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
548
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

721
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
721
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

381
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
381

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced coarsening induced by pore confinement.

Physical review. E·2025
Same author

Fenestration of the vertebral artery in a polytrauma patient: A vascular anatomical variant.

Journal de medecine vasculaire·2024
Same author

Clinical relevance and prognostic impact of the classification between multibacillary and paucibacillary forms of cutaneous tuberculosis: A 24-year retrospective multicenter study.

Annales de dermatologie et de venereologie·2024
Same author

From Delphi consensus to decision algorithm: Ethical considerations.

Annales de dermatologie et de venereologie·2024
Same author

The value of alpha-1 antitrypsin functional testing and genotyping for the diagnosis of the MS variant of alpha-1 antitrypsin deficiency-associated panniculitis.

Annales de dermatologie et de venereologie·2024
Same author

[Characteristics of radiotherapy for adolescents and young adults].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024

Related Experiment Video

Updated: Oct 8, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K

Radiotherapy of cervical cancer.

C Chargari1, K Peignaux2, A Escande3

  • 1Département d'oncologie radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94800 Villejuif, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|December 27, 2021
PubMed
Summary
This summary is machine-generated.

This study updates French Society of Oncological Radiotherapy recommendations for external beam radiotherapy and brachytherapy in cervical cancer management. It details indications and techniques for various stages, emphasizing brachytherapy

Keywords:
BrachytherapyCancers du col utérinCervical cancerChemoradiationChimioradiothérapieCuriethérapieFrench Society for Radiation OncologyGuidelinesImage-guided radiotherapyRadiation therapyRadiothérapieRadiothérapie guidée par l’imagerieRecommandationsSociété française de radiothérapie oncologique

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.0K

Related Experiment Videos

Last Updated: Oct 8, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.0K

Area of Science:

  • Oncology
  • Radiotherapy
  • Gynecologic Oncology

Background:

  • Cervical cancer treatment relies heavily on external beam radiotherapy and brachytherapy.
  • Treatment strategies vary based on tumor stage and risk factors.
  • Current guidelines require updates to reflect advancements in radiotherapy.

Purpose of the Study:

  • To present updated recommendations for cervical cancer radiotherapy from the French Society of Oncological Radiotherapy.
  • To outline indications and techniques for external beam radiotherapy and brachytherapy.
  • To provide guidance for managing early-stage, locally advanced, and post-operative cervical cancer.

Main Methods:

  • Review and update of existing clinical guidelines.
  • Consensus-based recommendations from the French Society of Oncological Radiotherapy.
  • Inclusion of histopathological criteria for treatment decisions.

Main Results:

  • Brachytherapy is recommended as a preoperative option for early-stage cervical cancer with local risk factors.
  • Postoperative radiotherapy is guided by specific histopathological findings.
  • Chemoradiation followed by a brachytherapy boost is standard for advanced local tumors.

Conclusions:

  • Updated recommendations provide a clear framework for radiotherapy in cervical cancer.
  • The guidelines emphasize the crucial role of brachytherapy in various treatment settings.
  • Adherence to these recommendations aims to optimize patient outcomes in cervical cancer management.